Collectively, in vitro and in vivo data demonstrate a significant reduction of tumor growth upon PTPRZ1 knock-down, prompting us to address the molecular mechanisms by which PTPRZ-B impacts on glioma cell behavior. Here, PTPRZ1 is linked to glioma.